Markets Gone Wild

Nemaura Medical Announces Pricing of Approximately $8.4 Million LOUGHBOROUGH, Jan. 27, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) On January 27, 2023, Nemaura Medical, Inc. made a groundbreaking announcement regarding its future plans. The medical technology company, known for its focus on developing non-invasive wearable sensors and personalized lifestyle programs, revealed that it…

Superalloys Market: Information By Product (Nickel-Based, Cobalt-Based and Iron-Based), By Application (Aerospace & Defense, Energy, Industrial Gas Turbine, Automotive, Oil & Gas) – Forecast till 2027 New York, USA, Jan. 27, 2023 (GLOBE NEWSWIRE) — According to a Comprehensive Research Report by Market Research Future (MRFR), the global superalloys market is set to reach USD…

Fintech: A Quirky Look at Fintech as a Service (FaaS) What is Fintech as a Service (FaaS)? Breaking Down the Buzzword Fintech as a service (FaaS) is not a new designation or trend. Fintech is an umbrella term for financial technology which in essence refers to any software app tailored to: Help automate and enhance…

Russell 2000 Technical Analysis: FOMC Meeting on the Horizon Market Trends In terms of Russell 2000 technical analysis, the market is trading carefully ahead of the FOMC meeting next week. The bulls had a good run recently ignoring the deterioration in leading indicators like PMIs and focusing more on the lagging ones like employment. The…

Daily Market Commentary Friday’s European Trading Session As Friday’s European trading session gets underway, the greenback is still carrying a positive momentum. However, the upside for the greenback is limited. A more in-depth analysis of the GDP data reveals that the growth was, to a large extent, driven by inventories, and therefore likely to fizzle…

It’s All Quiet on the Expiry Front There aren’t any major expiries to take note of for today and I’ve also included the ones for month-end next week as well. Looking through, there aren’t any significant ones to wrap up January either. As such, trading sentiment will revolve around the risk mood mostly but we…

Dupixent® (dupilumab) Recommended for Expanded EU Approval by the CHMP Introduction Exciting news in the world of dermatology as Dupixent is recommended for expanded EU approval by the CHMP to treat children as young as six months old with severe atopic dermatitis. If approved, Dupixent would be the first and only targeted medicine in the…

Yotta Acquisition Corporation Announces Extension of Combination Period and Additional Contribution Yotta Investment LLC Makes Significant Deposit into Company’s Trust Account NEW YORK, Jan. 26, 2023 (GLOBE NEWSWIRE) — Yotta Acquisition Corporation (NASDAQ: YOTA, the “Company”), a special purpose acquisition company, announced today that Yotta Investment LLC, the Company’s initial public offering sponsor (“Sponsor”), has…